Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

Influence of HLA class I and HLA-KIR compound genotypes on HIV-2 infection and markers of disease progression in a Manjako community in West Africa.

Yindom LM, Leligdowicz A, Martin MP, Gao X, Qi Y, Zaman SM, van der Loeff MS, van Tienen C, Jaye A, Aveika A, Worwui A, Diatta M, Vincent T, Whittle HC, Rowland-Jones SL, Walton R, Carrington M.

J Virol. 2010 Aug;84(16):8202-8. doi: 10.1128/JVI.00116-10.

2.

The HLA-C*04: 01/KIR2DS4 gene combination and human leukocyte antigen alleles with high population frequency drive rate of HIV disease progression.

Olvera A, Pérez-Álvarez S, Ibarrondo J, Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N, Gomez L, Sanchez J, Brander C.

AIDS. 2015 Mar 13;29(5):507-17. doi: 10.1097/QAD.0000000000000574.

PMID:
25715101
3.

Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.

Tiemessen CT, Paximadis M, Minevich G, Winchester R, Shalekoff S, Gray GE, Sherman GG, Coovadia AH, Kuhn L.

J Acquir Immune Defic Syndr. 2011 Jul 1;57(3):181-9. doi: 10.1097/QAI.0b013e3182174a76.

4.

High resolution human leukocyte antigen class I allele frequencies and HIV-1 infection associations in Chinese Han and Uyghur cohorts.

Liu Y, Zhao Z, Li T, Liao Q, Kushner N, Touzjian NY, Shao Y, Sun Y, Strong AJ, Lu Y.

PLoS One. 2012;7(12):e50656. doi: 10.1371/journal.pone.0050656.

5.

KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.

Habegger de Sorrentino A, Sinchi JL, Marinic K, López R, Iliovich E.

Immunology. 2013 Oct;140(2):273-9. doi: 10.1111/imm.12137.

6.

Associations of HLA class I antigen specificities and haplotypes with disease progression in HIV-1-infected Hans in Northern China.

Zhang H, Zhao B, Han X, Wang Z, Liu B, Lu C, Zhang M, Liu J, Chen O, Hu Q, Jiang F, Shang H.

Hum Immunol. 2013 Dec;74(12):1636-42. doi: 10.1016/j.humimm.2013.08.287.

PMID:
24012585
7.

Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.

Jennes W, Verheyden S, Demanet C, Menten J, Vuylsteke B, Nkengasong JN, Kestens L.

PLoS One. 2011 Feb 14;6(2):e17043. doi: 10.1371/journal.pone.0017043.

8.

HLA class I, KIR, and genome-wide SNP diversity in the RV144 Thai phase 3 HIV vaccine clinical trial.

Prentice HA, Ehrenberg PK, Baldwin KM, Geretz A, Andrews C, Nitayaphan S, Rerks-Ngarm S, Kaewkungwal J, Pitisuttithum P, O'Connell RJ, Robb ML, Kim JH, Michael NL, Thomas R.

Immunogenetics. 2014 May;66(5):299-310. doi: 10.1007/s00251-014-0765-6.

PMID:
24682434
9.

Association of HLA class-I and inhibitory KIR genotypes in Gabonese patients infected by Chikungunya or Dengue type-2 viruses.

Petitdemange C, Wauquier N, Jacquet JM, Theodorou I, Leroy E, Vieillard V.

PLoS One. 2014 Sep 29;9(9):e108798. doi: 10.1371/journal.pone.0108798.

10.

Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.

Gaudieri S, Nolan D, McKinnon E, Witt CS, Mallal S, Christiansen FT.

Mol Immunol. 2005 Feb;42(4):557-60. Review.

PMID:
15607813
11.

Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.

Payne RP, Branch S, Kløverpris H, Matthews PC, Koofhethile CK, Strong T, Adland E, Leitman E, Frater J, Ndung'u T, Hunter E, Haubrich R, Mothe B, Edwards A, Riddell L, Chen F, Harrigan PR, Brumme ZL, Mallal S, John M, Jooste JP, Shapiro R, Deeks SG, Walker BD, Brander C, Landis C, Carlson JM, Prado JG, Goulder PJ.

J Virol. 2014 May;88(9):4668-78. doi: 10.1128/JVI.03303-13.

12.

Distribution of HLA-A, -B, and -C alleles and HLA/KIR combinations in Han population in China.

Shen Y, Cao D, Li Y, Kulski JK, Shi L, Jiang H, Ma Q, Yu J, Zhou J, Yao Y, Shi L.

J Immunol Res. 2014;2014:565296. doi: 10.1155/2014/565296.

13.

Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.

Tajik N, Shahsavar F, Nasiri M, Radjabzadeh MF.

Int J Immunogenet. 2010 Jun;37(3):159-68. doi: 10.1111/j.1744-313X.2010.00906.x.

PMID:
20193031
14.
15.

Killer Cell Immunoglobulin-Like Receptor Alleles Alter HIV Disease in Children.

Singh KK, Qin M, Brummel SS, Angelidou K, Trout RN, Fenton T, Spector SA.

PLoS One. 2016 Mar 16;11(3):e0151364. doi: 10.1371/journal.pone.0151364.

16.

Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands.

Jennes W, Verheyden S, Demanet C, Adjé-Touré CA, Vuylsteke B, Nkengasong JN, Kestens L.

J Immunol. 2006 Nov 15;177(10):6588-92.

17.

HLA-B*57 Micropolymorphism shapes HLA allele-specific epitope immunogenicity, selection pressure, and HIV immune control.

Kloverpris HN, Stryhn A, Harndahl M, van der Stok M, Payne RP, Matthews PC, Chen F, Riddell L, Walker BD, Ndung'u T, Buus S, Goulder P.

J Virol. 2012 Jan;86(2):919-29. doi: 10.1128/JVI.06150-11.

18.

Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.

Tajik N, Shah-hosseini A, Mohammadi A, Jafari M, Nasiri M, Radjabzadeh MF, Farnia P, Jalali A.

Tissue Antigens. 2012 Feb;79(2):90-6. doi: 10.1111/j.1399-0039.2011.01812.x.

PMID:
22128749
19.

KIR-HLA and maternal-infant HIV-1 transmission in sub-Saharan Africa.

Paximadis M, Minevich G, Winchester R, Schramm DB, Gray GE, Sherman GG, Coovadia AH, Kuhn L, Tiemessen CT.

PLoS One. 2011 Feb 8;6(2):e16541. doi: 10.1371/journal.pone.0016541.

20.

Human leukocyte antigen class I supertypes and HIV-1 control in African Americans.

Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, Gardner LI, McNicholl JM, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA; HIV Epidemiology Research Study.; Reaching for Excellence in Adolescent Care and Health Study..

J Virol. 2010 Mar;84(5):2610-7. doi: 10.1128/JVI.01962-09.

Items per page

Supplemental Content

Support Center